UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

§ 240.13d-2(a)

(Amendment No. 4)¹

Sysorex, Inc.

(Name of Issuer)

Common Stock, par value $0.00001 per share

(Title of Class of Securities)

87185L206

(CUSIP Number)

MICHAEL BIGGER

BIGGER CAPITAL FUND, LP

2250 Red Springs Drive

Las Vegas, NV 89135

(631) 987-0235

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

August 10, 2023

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

* Consists of (i) 40,952 shares of the Issuer’s Common Stock, par value $0.00001 per share (the “Common Stock”) and (ii) 70,000 shares of Common Stock which have been issued upon conversion of the 12.5% Original Issue Discount Senior Secured Convertible Debentures (the “Debentures”), subject to a 9.99% blocker. Does not consist of (i) 65,896 shares of Common Stock issuable upon the exercise of warrants that are exercisable within 60 days because the warrants are subject to a 9.99% blocker and (ii) additional shares of Common Stock issuable upon conversion of the Debentures because the Debentures are subject to a 9.99% blocker.

* Consists of (i) 40,952 shares of Common Stock and (ii) 70,000 shares of Common Stock which have been issued upon conversion of the Debentures, subject to a 9.99% blocker. Does not consist of (i) 65,896 shares of Common Stock issuable upon the exercise of warrants that are exercisable within 60 days because the warrants are subject to a 9.99% blocker and (ii) additional shares of Common Stock issuable upon conversion of the Debentures because the Debentures are subject to a 9.99% blocker.

* Consists of (i) 40,000 shares of Common Stock and (ii) 70,000 shares of Common Stock which have been issued upon conversion of the Debentures, subject to a 9.99% blocker. Does not consist of (i) 65,399 shares of Common Stock issuable upon the exercise of warrants that are exercisable within 60 days because the warrants are subject to a 9.99% blocker and (ii) additional shares of Common Stock issuable upon conversion of the Debentures because the Debentures are subject to a 9.99% blocker.

* Consists of (i) 40,000 shares of Common Stock and (ii) 70,000 shares of Common Stock which have been issued upon conversion of the Debentures, subject to a 9.99% blocker. Does not consist of (i) 65,399 shares of Common Stock issuable upon the exercise of warrants that are exercisable within 60 days because the warrants are subject to a 9.99% blocker and (ii) additional shares of Common Stock issuable upon conversion of the Debentures because the Debentures are subject to a 9.99% blocker.

* Consists of (i) 40,000 shares of Common Stock and (ii) 70,000 shares of Common Stock which have been issued upon conversion of the Debentures, subject to a 9.99% blocker. Does not consist of (i) 65,399 shares of Common Stock issuable upon the exercise of warrants that are exercisable within 60 days because the warrants are subject to a 9.99% blocker and (ii) additional shares of Common Stock issuable upon conversion of the Debentures because the Debentures are subject to a 9.99% blocker.

* Consists of (i) 40,000 shares of Common Stock and (ii) 70,000 shares of Common Stock which have been issued upon conversion of the Debentures, subject to a 9.99% blocker. Does not consist of (i) 65,399 shares of Common Stock issuable upon the exercise of warrants that are exercisable within 60 days because the warrants are subject to a 9.99% blocker and (ii) additional shares of Common Stock issuable upon conversion of the Debentures because the Debentures are subject to a 9.99% blocker.

* Consists of (i) 110,952 shares of Common Stock owned by Bigger Capital, (ii) 110,000 shares of Common Stock owned by District 2 CF and (iii) 2,325 shares of Common Stock directly owned by Michael Bigger’s IRA. Does not consist of (i) shares of Common Stock issuable upon the exercise of warrants that are exercisable within 60 days because the warrants are subject to a 9.99% blocker and (ii) additional shares of Common Stock issuable upon conversion of the Debentures because the Debentures are subject to a 9.99% blocker.

The following constitutes Amendment No. 4 to the Schedule 13D filed by the undersigned (“Amendment No. 4”). This Amendment No. 4 amends the Schedule 13D as specifically set forth herein. The amount of shares of Common Stock listed in this Amendment No. 4 reflect the 1-for-1,000 reverse stock split undertaken by the Issuer that became effective on August 7, 2023.

Item 3 is hereby amended and restated as follows:

The Shares purchased by each of Bigger Capital and District 2 CF were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases and private transactions, as further described in Item 6 of the Schedule 13D filed on October 11, 2022 (the “Initial 13D”), Item 6 of Amendment No. 2 to Schedule 13D filed on October 19, 2022 (“Amendment No. 2”), Item 6 of Amendment No. 3 to Schedule 13D filed on February 17, 2023 (“Amendment No. 3”) and Item 6 of this Amendment No. 4. The Shares purchased by Mr. Bigger were purchased with personal funds (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases. The aggregate purchase price of the 110,952 Shares beneficially owned by Bigger Capital is approximately $1,543,686, excluding brokerage commissions. The aggregate purchase price of the 110,000 Shares beneficially owned by District 2 CF is approximately $1,025,000, excluding brokerage commissions. The aggregate purchase price of the 2,325 Shares beneficially owned by Mr. Bigger’s IRA is approximately $28,320, excluding brokerage commissions. The purchase prices reflected in this Item 3 reflect the purchases related to the Debentures and the warrants as further described in Item 6 of the Initial 13D, Item 6 of Amendment No. 2, Item 6 of Amendment No. 3 and Item 6 of this Amendment No. 4.

Items 5(a) – (c) and (e) are hereby amended and restated as follows:

The aggregate percentage of Shares reported owned by each Reporting Person is based upon 2,484,427 Shares outstanding as of August 14, 2023, which is the total number of Shares outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on August 14, 2023.

The ownership of each Reporting Person in this Item 5 does not reflect the additional Debentures nor the warrants that are further described in Item 6 of the Initial 13D, Item 6 of Amendment No. 2, Item 6 of Amendment No. 3 and Item 6 of this Amendment No. 4. If such Debentures were converted or such warrants were exercised, the amount of Shares described below would be higher.

Percentage: Approximately 4.5%

Percentage: Approximately 4.5%

Percentage: Approximately 4.4%

Percentage: Approximately 4.4%

Percentage: Approximately 4.4%

Percentage: Approximately 4.4%

Percentage: Approximately 9.0%

Each Reporting Person may be deemed to be a member of a “group” with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, and, accordingly, may be deemed the beneficial owner of the Shares directly owned by the other Reporting Persons.

Item 6 is hereby amended to add the following:

On August 10, 2023, Bigger Capital and District 2 CF each received shares of Common Stock and warrants directly from the Issuer. Pursuant to the terms of the SPA, if a registration statement was not effective within 90 days following the closing of the SPA to register the securities and underlying securities issued pursuant to the SPA, the Issuer agreed to issue each of Bigger Capital and District 2 CF (i) a number of additional shares of Common Stock equal to 10% of the number of shares of Common Stock acquired, adjusted for any forward or reverse stock splits of the Common Stock, for each month that such registration statement was not effective until such shares could be sold pursuant to Rule 144 (the “Additional Shares”) and (ii) a new warrant equal to the number of Additional Shares, to acquire one share of Common Stock at an exercise price of $0.001 per share, which exercise price will not be subject to adjustment as a result of any forward or reverse split of the Common Stock (each, a “Warrant 3”). The terms of Warrant 3 issued to each of Bigger Capital and District 2 CF on August 10, 2023 are the same as the terms of Warrant 1 and Warrant 2 described in Item 6 of Amendment No. 2.

Each of Bigger Capital and District 2 CF received 15,000 shares of Common Stock and 15,000 Warrant 3s, of which 15,000 shares of Common Stock are issuable upon full exercise of such Warrant 3s.

Other than as described herein and in the Initial 13D, Amendment No. 1, Amendment No. 2 and Amendment No. 3, there are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer.

Item 7 is hereby amended to add the following:

The form of Warrant 1 and Warrant 2 and the SPA described in Item 6 of this Amendment No. 4 were previously filed as Exhibits 4.1, 4.2 and 10.1, respectively, in Item 7 of Amendment No. 2. The Form of Warrant 3 is hereby filed as follows:

SIGNATURE

After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: August 23, 2023